Sofosbuvir/Velpatasvir Fixed Dose Combination
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Sofosbuvir/Velpatasvir Fixed Dose Combination, covering 2017-06-01 to 2022-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis [Phase 3]